Learning Objective 1: Review the history of drug development for migraine

Learning Objective 2: Understand role of CGRP in migraine pathogenesis

Learning Objective 3: Understand potential new therapies for migraine targeting CGRP



Session date: 
05/09/2017 - 8:00am to 9:00am CDT
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Steven Meyers, MD